Search
Cerus Corp
CERSAdd to Watchlist
2.610USD
+0.010+0.38%
Close 09-24 16:00（ET）
522.97MMarket Cap
LossP/E TTM
About Cerus Corp Company
Cerus Corporation is a biomedical products company. The Company is focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on its proprietary technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Its INTERCEPT Blood System is intended for use with blood components and certain of their derivatives: platelets, plasma, red blood cells and to produce INTERCEPT Fibrinogen Complex (IFC), and pathogen reduced plasma, cryoprecipitate reduced. The INTERCEPT Blood System for Cryoprecipitation uses its plasma system to produce IFC for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. In addition, the INTERCEPT Blood System for Cryoprecipitation is used to produce pathogen reduced plasma, cryoprecipitate reduced.
Cerus Corp Profile
Ticker SymbolCERS
Company nameCerus Corp
IPO dateJan 31, 1997
CEOGreenman (William M)
Number of employees281
Security typeOrdinary Share
Fiscal year-endJan 31
Address1220 Concord Avenue
CityCONCORD
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94520
Phone19252886000
Websitehttps://www.cerus.com/
Ticker SymbolCERS
IPO dateJan 31, 1997
CEOGreenman (William M)
Company Executives of Cerus Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Kevin Dennis Green, CPA
Mr. Kevin Dennis Green, CPA
Chief Financial Officer
Chief Financial Officer
503.14K
+5.95%
Mr. Kevin Dennis Green, CPA
Mr. Kevin Dennis Green, CPA
Chief Financial Officer
Chief Financial Officer
503.14K
+5.95%
Mr. Kevin Dennis Green, CPA
Mr. Kevin Dennis Green, CPA
Chief Financial Officer
Chief Financial Officer
503.14K
+5.95%
Mr. Eric H. Bjerkholt
Mr. Eric H. Bjerkholt
Independent Director
Independent Director
201.68K
+19.61%
Mr. Eric H. Bjerkholt
Mr. Eric H. Bjerkholt
Independent Director
Independent Director
201.68K
+19.61%
Mr. Eric H. Bjerkholt
Mr. Eric H. Bjerkholt
Independent Director
Independent Director
201.68K
+19.61%
Ms. Ann Lucena
Ms. Ann Lucena
Independent Director
Independent Director
172.28K
+34.83%
Ms. Ann Lucena
Ms. Ann Lucena
Independent Director
Independent Director
172.28K
+34.83%
Ms. Ann Lucena
Ms. Ann Lucena
Independent Director
Independent Director
172.28K
+34.83%
Dr. Hua Shan, M.D., Ph.D.
Dr. Hua Shan, M.D., Ph.D.
Independent Director
Independent Director
132.39K
+45.32%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Kevin Dennis Green, CPA
Mr. Kevin Dennis Green, CPA
Chief Financial Officer
Chief Financial Officer
503.14K
+5.95%
Mr. Kevin Dennis Green, CPA
Mr. Kevin Dennis Green, CPA
Chief Financial Officer
Chief Financial Officer
503.14K
+5.95%
Mr. Kevin Dennis Green, CPA
Mr. Kevin Dennis Green, CPA
Chief Financial Officer
Chief Financial Officer
503.14K
+5.95%
Mr. Eric H. Bjerkholt
Mr. Eric H. Bjerkholt
Independent Director
Independent Director
201.68K
+19.61%
Mr. Eric H. Bjerkholt
Mr. Eric H. Bjerkholt
Independent Director
Independent Director
201.68K
+19.61%
Mr. Eric H. Bjerkholt
Mr. Eric H. Bjerkholt
Independent Director
Independent Director
201.68K
+19.61%
FAQs
Who are the top five shareholders of Cerus Corp?
The top five shareholders of Cerus Corp are: Mr. Kevin Dennis Green, CPA
How many institutions hold shares of Cerus Corp (CERS)?
As of 2026Q1, 277 institutions hold shares of Cerus Corp, with a combined market value of approximately 147.40M, accounting for 73.57% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 4480533.00.